Insights

Strategic Collaborations SOPHiA GENETICS has formed recent high-profile partnerships with leading biotech companies such as Element Biosciences and A.D.A.M. Innovations, indicating an active drive to integrate advanced sequencing technology and expand its market reach in genomics and precision medicine. These collaborations present opportunities to offer complementary technological solutions or joint services to enhance research capabilities and streamline workflows.

Expanding Product Portfolio The launch of AI-powered Digital Twins and the development of liquid biopsy companion diagnostics demonstrate SOPHiA GENETICS's focus on innovative, AI-driven tools for oncology and cancer diagnostics, opening avenues to introduce advanced analytics, data management, and AI integration services tailored for clinical and research institutions.

Global Expansion and Outreach Participation in key industry events such as the AMP Annual Meeting and engagement in collaborations across different regions like Japan suggest ongoing efforts to broaden global customer engagement. This provides sales opportunities to target labs, research centers, and hospitals seeking to adopt cutting-edge precision medicine solutions worldwide.

Technological Edge SOPHiA GENETICS’s platform based on AI and collective data learning offers a compelling value proposition for organizations seeking to enhance genomic data analysis and diagnostics. Selling complementary AI tools, cloud data management, or integration solutions can capitalize on their technological leadership and customer base.

Financial Growth Potential With reported revenues between 50 and 100 million dollars and active international expansion through partnerships, SOPHiA GENETICS presents a promising opportunity for sales solutions that support scaling operations, improve data infrastructure, and optimize clinical workflows to facilitate sustained growth in the competitive biotech landscape.

SOPHiA GENETICS Tech Stack

SOPHiA GENETICS uses 8 technology products and services including BootstrapCDN, GitLab CI, Articulate 360, and more. Explore SOPHiA GENETICS's tech stack below.

  • BootstrapCDN
    Content Delivery Network
  • GitLab CI
    Continuous Integration
  • Articulate 360
    Education Management
  • SAML
    Identity And Access Management
  • IBM
    IT
  • Vyond
    Marketing
  • Workable
    Recruitment Marketing
  • HTTP/3
    Web & Portal Technology

Media & News

SOPHiA GENETICS's Email Address Formats

SOPHiA GENETICS uses at least 1 format(s):
SOPHiA GENETICS Email FormatsExamplePercentage
FLast@sophiagenetics.comJDoe@sophiagenetics.com
59%
First.Last@sophiagenetics.comJohn.Doe@sophiagenetics.com
38%
FirstLast@sophiagenetics.comJohnDoe@sophiagenetics.com
2%
First.L@sophiagenetics.comJohn.D@sophiagenetics.com
1%

Frequently Asked Questions

Where is SOPHiA GENETICS's headquarters located?

Minus sign iconPlus sign icon
SOPHiA GENETICS's main headquarters is located at La Pièce 12, Rolle, 1180, CH. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is SOPHiA GENETICS's phone number?

Minus sign iconPlus sign icon
You can contact SOPHiA GENETICS's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SOPHiA GENETICS's stock symbol?

Minus sign iconPlus sign icon
SOPHiA GENETICS is a publicly traded company; the company's stock symbol is SOPH.

What is SOPHiA GENETICS's official website and social media links?

Minus sign iconPlus sign icon
SOPHiA GENETICS's official website is sophiagenetics.com and has social profiles on LinkedInCrunchbase.

What is SOPHiA GENETICS's SIC code NAICS code?

Minus sign iconPlus sign icon
SOPHiA GENETICS's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does SOPHiA GENETICS have currently?

Minus sign iconPlus sign icon
As of October 2025, SOPHiA GENETICS has approximately 515 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Technology Officer: A. V.Chief Financial Officer: G. C.Chief Scientific Officer: Z. X.. Explore SOPHiA GENETICS's employee directory with LeadIQ.

What industry does SOPHiA GENETICS belong to?

Minus sign iconPlus sign icon
SOPHiA GENETICS operates in the Biotechnology Research industry.

What technology does SOPHiA GENETICS use?

Minus sign iconPlus sign icon
SOPHiA GENETICS's tech stack includes BootstrapCDNGitLab CIArticulate 360SAMLIBMVyondWorkableHTTP/3.

What is SOPHiA GENETICS's email format?

Minus sign iconPlus sign icon
SOPHiA GENETICS's email format typically follows the pattern of FLast@sophiagenetics.com. Find more SOPHiA GENETICS email formats with LeadIQ.

How much funding has SOPHiA GENETICS raised to date?

Minus sign iconPlus sign icon
As of October 2025, SOPHiA GENETICS has raised $15M in funding. The last funding round occurred on May 02, 2024 for $15M.

When was SOPHiA GENETICS founded?

Minus sign iconPlus sign icon
SOPHiA GENETICS was founded in 2011.
SOPHiA GENETICS

SOPHiA GENETICS

Biotechnology ResearchSwitzerland501-1000 Employees

SOPHiA GENETICS was founded in 2011 by biologists who had a vision to create a technology that could make a positive and lasting impact on the world, using data for good. 
 
We’ve built a revolutionary technology platform, SOPHiA DDM™, that rapidly distills complex data into actionable insights, enabling clinicians, researchers, and biopharma to reshape the way that we diagnose and treat cancer and rare inherited disorders. 
 
The AI fueling our platform learns from the complex genomic and multimodal data provided by our community of users to create a collective intelligence over time. By using the power of data and AI, we are expanding access to data-driven medicine and enabling the patients of today to help the patients of tomorrow. 
 
Our science is driven by unrelenting passion for our mission to transform patient care by expanding access to data-driven medicine globally. 

We wouldn’t be able to achieve all that we have – and all that we will – without our people, who are driven by our shared purpose to ensure that every patient worldwide has equitable access to precision medicine. 

Our virtues are our behaviors we exhibit every day, and our mantra “We Care” is our driving force.

Section iconCompany Overview

Headquarters
La Pièce 12, Rolle, 1180, CH
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SOPH
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
501-1000

Section iconFunding & Financials

  • $15M

    SOPHiA GENETICS has raised a total of $15M of funding over 8 rounds. Their latest funding round was raised on May 02, 2024 in the amount of $15M.

  • $50M$100M

    SOPHiA GENETICS's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $15M

    SOPHiA GENETICS has raised a total of $15M of funding over 8 rounds. Their latest funding round was raised on May 02, 2024 in the amount of $15M.

  • $50M$100M

    SOPHiA GENETICS's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.